Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-15 5:37 pm Unchanged | 2026-04-15 | 13D | BIOMX INC PAR $0.0001 PHGE | James E. Flynn | 989,056 9.990% | 0 (Unchanged) | Filing History |
| 2026-04-14 08:00 am Purchase | 2026-04-10 | 13D | BIOMX INC PAR $0.0001 PHGE | T3 Defense Inc. DFNS | 1,600,000 20.400% | 300,000 (+23.08%) | Filing History |
| 2026-04-10 3:40 pm Purchase | 2026-04-10 | 13D | BIOMX INC PAR $0.0001 PHGE | T3 Defense Inc. DFNS | 1,300,000 19.870% | 1,300,000 (New Position) | Filing History |
| 2026-02-17 4:47 pm Sale | 2025-12-31 | 13G | BIOMX INC PHGE | Alyeska Investment Group L.P. | 38,176 2.500% | -83,723 (-68.68%) | Filing History |
| 2026-02-13 5:03 pm Purchase | 2025-12-31 | 13G | BIOMX INC PAR $0.0001 PHGE | Nantahala Capital Management, LLC | 156,696 9.990% | 25,422 (+19.37%) | Filing History |
| 2026-02-11 7:24 pm Purchase | 2026-02-09 | 13D | BIOMX INC PAR $0.0001 PHGE | James E. Flynn | 989,056 9.990% | 170,190 (+20.78%) | Filing History |
| 2026-01-29 8:33 pm Sale | 2025-12-31 | 13G | BIOMX INC PHGE | Orin Hirschman | 38,175 0.100% | -44,296 (-53.71%) | Filing History |
| 2026-01-26 4:05 pm Purchase | 2025-12-26 | 13D | BIOMX INC PHGE | Yeganeh Reuven | 381,422 19.990% | 381,422 (New Position) | Filing History |
| 2025-08-07 4:15 pm Sale | 2025-07-31 | 13G | BIOMX INC PHGE | MORGAN STANLEY MS | 0 0.000% | -97,581 (Position Closed) | Filing History |
| 2025-08-05 3:15 pm Purchase | 2025-06-30 | 13G | BIOMX INC PHGE | MORGAN STANLEY MS | 97,581 7.100% | 97,581 (New Position) | Filing History |
| 2025-06-23 5:08 pm Sale | 2025-06-18 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 14,534 1.000% | -79,559 (-84.55%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | BIOMX INC PHGE | Nantahala Capital Management, LLC | 131,274 9.990% | 36,846 (+39.02%) | Filing History |
| 2025-05-15 4:29 pm Purchase | 2025-03-31 | 13G | BIOMX INC PHGE | Alyeska Investment Group L.P. | 121,899 9.270% | 121,899 (New Position) | Filing History |
| 2025-05-15 4:05 pm Purchase | 2025-04-21 | 13G | BIOMX INC PHGE | Rodney Hodges | 103,705 7.600% | 74,217 (+251.69%) | Filing History |
| 2025-05-08 07:39 am Purchase | 2025-03-31 | 13G | BIOMX INC PHGE | Orin Hirschman | 82,471 6.300% | 82,471 (New Position) | Filing History |
| 2025-03-04 5:34 pm Sale | 2025-02-27 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 131,269 9.990% | -84,234 (-39.09%) | Filing History |
| 2025-03-03 7:04 pm Unchanged | 2025-02-27 | 13D | BIOMX INC PHGE | James E. Flynn | 818,866 9.990% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 215,503 19.990% | 166,395 (+338.83%) | Filing History |
| 2024-11-13 5:30 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | Nantahala Capital Management, LLC | 94,428 9.990% | 94,428 (New Position) | Filing History |
| 2024-11-13 5:14 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | AMR Action Fund L.P. | 46,152 4.900% | 30,074 (+187.05%) | Filing History |